Natural Product: NPC569873

Natural Product IDNPC569873
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Icosa-5,11,14-trienoic acid
IUPAC Name icosa-5,11,14-trienoic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey PRHHYVQTPBEDFE-UHFFFAOYSA-N
Standard InCHI InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,15-16H,2-5,8,11-14,17-19H2,1H3,(H,21,22)
SMILES CCCCCC=CCC=CCCCCC=CCCCC(=O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   306.26 Volume:   361.511
?
Van der Waals volume.
Dense:   0.847 LogP:   7.603
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   3.793
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -5.885
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   15.0 Rigid Bonds:   4.0
TPSA:   37.3
?
Topological Polar Surface Area.
H-Bond Acceptor:   2.0
H-Bond Donor:   1.0 Rings:   0.0
Heavy Atoms:   2.0

MedChem Properties

QED Drug-Likeness Score:   0.279 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.56 Fsp3:   0.65
MCE-18:   0.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Accepted GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.257 Fluc inhibitor:   0.322
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.004
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.008
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.994 Promiscuous compounds:   0.601

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.104 MDCK Permeability:   -4.92
Pgp-inhibitor:   0.0 Pgp-substrate:   0.003
PAMPA:   0.373
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.082
20% Bioavailability (F20%):   0.027 30% Bioavailability (F30%):   0.282
50% Bioavailability (F50%):   0.136

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.056 MRP1:   0.988
Plasma Protein Binding (PPB):   98.257% Volume Distribution (VD):   -0.738
Fu: 1.119%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.311
OATP1B3 inhibitor:   0.979 BCRP inhibitor:   0.016
BSEP inhibitor:   0.512

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.948
CYP2C19-inhibitor:   0.997 CYP2C19-substrate:   0.33
CYP2C9-inhibitor:   1.0 CYP2C9-substrate:   0.008
CYP2D6-inhibitor:   0.998 CYP2D6-substrate:   0.004
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   1.0
CYP2B6-substrate:   1.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.203
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  5.325 Half-life (T1/2):  0.385

ADMET: Toxicity

hERG Blockers:  0.124 hERG Blockers (10um):  0.258
Human Hepatotoxicity (H-HT):  0.058 Drug-induced Liver Injury (DILI):  0.0
AMES Toxicity:  0.211 Rat Oral Acute Toxicity:  0.042
Maximum Recommended Daily Dose:  0.053 Skin Sensitization:  1.0
Carcinogencity:  0.054 Eye Corrosion:  1.0
Eye Irritation:  0.999 Respiratory Toxicity:  0.466
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.152
Hematotoxicity:  0.005 Drug-induced Nephrotoxicity:  0.338
Genotoxicity:  0.0 RPMI-8226 Immunitoxicity:  0.033
A549 Cytotoxicity:  0.165 Hek293 Cytotoxicity:  0.044
BCF:   1.244
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.091
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.457
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   2.977
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[38263385]
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[39345860]
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. PMID[6253598]
NPO17850 Torreya grandis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO17491 Torreya nuncifera Species Taxaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO17491 Torreya nuncifera Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO17850 Torreya grandis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO17850 Torreya grandis Species Taxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO23682 Juniperus phoenicea Species Cupressaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC569873 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC91495
0.9655 High Similarity NPC59051
0.8667 High Similarity NPC321062
0.8667 High Similarity NPC5413
0.8387 Intermediate Similarity NPC154245
0.8387 Intermediate Similarity NPC85813
0.8387 Intermediate Similarity NPC223697
0.8387 Intermediate Similarity NPC6095
0.7667 Intermediate Similarity NPC117572
0.7568 Intermediate Similarity NPC323597
0.7568 Intermediate Similarity NPC211752
0.7568 Intermediate Similarity NPC323498
0.75 Intermediate Similarity NPC70387
0.7419 Intermediate Similarity NPC424
0.7419 Intermediate Similarity NPC36061
0.7419 Intermediate Similarity NPC69510
0.7419 Intermediate Similarity NPC77272
0.7419 Intermediate Similarity NPC290563
0.7419 Intermediate Similarity NPC139029
0.7419 Intermediate Similarity NPC281972
0.7419 Intermediate Similarity NPC92114
0.7419 Intermediate Similarity NPC261831
0.7419 Intermediate Similarity NPC87564
0.7273 Intermediate Similarity NPC52955
0.7273 Intermediate Similarity NPC88966
0.7273 Intermediate Similarity NPC25417
0.7273 Intermediate Similarity NPC1813
0.7188 Intermediate Similarity NPC149821
0.7097 Intermediate Similarity NPC281245
0.6829 Remote Similarity NPC322461
0.6667 Remote Similarity NPC95145
0.6667 Remote Similarity NPC325642
0.6667 Remote Similarity NPC207292
0.6667 Remote Similarity NPC65174
0.6667 Remote Similarity NPC605544
0.6667 Remote Similarity NPC607260
0.6512 Remote Similarity NPC329249
0.65 Remote Similarity NPC320305
0.65 Remote Similarity NPC317583
0.65 Remote Similarity NPC321838
0.6471 Remote Similarity NPC48162
0.6341 Remote Similarity NPC325977
0.6341 Remote Similarity NPC320642
0.6341 Remote Similarity NPC327112
0.6341 Remote Similarity NPC329550
0.619 Remote Similarity NPC328311
0.619 Remote Similarity NPC323045
0.619 Remote Similarity NPC317881
0.6053 Remote Similarity NPC323436
0.6053 Remote Similarity NPC327388
0.5778 Remote Similarity NPC92558
0.575 Remote Similarity NPC477201
0.5667 Remote Similarity NPC155263
0.5641 Remote Similarity NPC487561
0.5556 Remote Similarity NPC224227
0.5484 Remote Similarity NPC171736
0.5484 Remote Similarity NPC301585
0.5484 Remote Similarity NPC261080
0.5484 Remote Similarity NPC132565
0.5484 Remote Similarity NPC209970
0.5484 Remote Similarity NPC216630
0.5484 Remote Similarity NPC201844
0.5484 Remote Similarity NPC301696
0.5484 Remote Similarity NPC196924
0.5484 Remote Similarity NPC307783
0.5484 Remote Similarity NPC154186
0.5484 Remote Similarity NPC149184
0.5484 Remote Similarity NPC279026
0.5484 Remote Similarity NPC113928
0.5484 Remote Similarity NPC14227
0.5476 Remote Similarity NPC243532
0.5476 Remote Similarity NPC473863
0.5366 Remote Similarity NPC106851
0.5366 Remote Similarity NPC282788
0.5366 Remote Similarity NPC274927
0.5357 Remote Similarity NPC174368
0.5349 Remote Similarity NPC68343
0.5349 Remote Similarity NPC328089
0.5333 Remote Similarity NPC175342
0.525 Remote Similarity NPC606120
0.5238 Remote Similarity NPC179764
0.5135 Remote Similarity NPC87394
0.5122 Remote Similarity NPC325734
0.5116 Remote Similarity NPC251042
0.5116 Remote Similarity NPC255863
0.5116 Remote Similarity NPC174447
0.5116 Remote Similarity NPC136164
0.5116 Remote Similarity NPC122521
0.5116 Remote Similarity NPC245947
0.5111 Remote Similarity NPC49863
0.5102 Remote Similarity NPC322457

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC569873 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8667 High Similarity NPD3173 Phase 4
0.8387 Intermediate Similarity NPD4266 Phase 2
0.7667 Intermediate Similarity NPD4222 Phase 3
0.7419 Intermediate Similarity NPD3195 Phase 2
0.7419 Intermediate Similarity NPD3196 Approved
0.7368 Intermediate Similarity NPD39 Phase 4
0.7273 Intermediate Similarity NPD3172 Approved
0.6341 Remote Similarity NPD4246 Phase 2
0.6053 Remote Similarity NPD3194 Phase 4
0.5714 Remote Similarity NPD3174 Discontinued
0.5484 Remote Similarity NPD2270 Pre-clinical
0.5484 Remote Similarity NPD633 Phase 3
0.5484 Remote Similarity NPD9448 Phase 2
0.5111 Remote Similarity NPD4247 Clinical (unspecified phase)

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data